Lv5
920 积分 2021-09-28 加入
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus Nephritis
3个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus Nephritis
3个月前
已完结
25-Hydroxyvitamin D levels are associated with mortality and cardiovascular events in systemic lupus erythematosus
7个月前
已关闭
皖公网安备34019202002308
